Innovita Biological Technology Co., Ltd. (SHA:688253)

Market Cap	4.92B +15.0%
Revenue (ttm)	422.03M -32.1%
Net Income	146.04M -40.8%
EPS	1.07 -40.9%
Shares Out	134.87M
PE Ratio	34.10
Forward PE	28.96
Dividend	0.56 (1.53%)
Ex-Dividend Date	n/a

Volume	1,025,430
Average Volume	2,207,543
Open	35.71
Previous Close	36.03
Day's Range	35.71 - 36.84
52-Week Range	27.56 - 40.88
Beta	1.00
RSI	49.63
Earnings Date	Apr 28, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 558
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688253

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 146.04 million, a decrease of -40.84%.